Ravenquest Biomed Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Ravenquest Biomed recent Real Value cannot be determined due to lack of data. The prevailing price of Ravenquest Biomed is $0.0. Our model determines the value of Ravenquest Biomed from analyzing the company fundamentals such as Return On Equity of -1.12, shares owned by insiders of 10.51 %, and Current Valuation of 11.72 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Ravenquest Biomed's price fluctuation is out of control at this time. Calculation of the real value of Ravenquest Biomed is based on 3 months time horizon. Increasing Ravenquest Biomed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ravenquest pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Ravenquest Biomed. Since Ravenquest Biomed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ravenquest Pink Sheet. However, Ravenquest Biomed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The real value of Ravenquest Pink Sheet, also known as its intrinsic value, is the underlying worth of Ravenquest Biomed Company, which is reflected in its stock price. It is based on Ravenquest Biomed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ravenquest Biomed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ravenquest Biomed helps investors to forecast how Ravenquest pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ravenquest Biomed more accurately as focusing exclusively on Ravenquest Biomed's fundamentals will not take into account other important factors: Ravenquest Biomed Total Value Analysis
Ravenquest Biomed is at this time projected to have takeover price of 11.72 M with market capitalization of 48.21 K, debt of 0, and cash on hands of 749.13 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ravenquest Biomed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.72 M | 48.21 K | 0 | 749.13 K |
Ravenquest Biomed Investor Information
The company has price-to-book ratio of 0.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ravenquest Biomed recorded a loss per share of 0.22. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Ravenquest Biomed's historical financial statements, Ravenquest Biomed is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Ravenquest Biomed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ravenquest Biomed has an asset utilization ratio of 3.33 percent. This implies that the Company is making $0.0333 for each dollar of assets. An increasing asset utilization means that Ravenquest Biomed is more efficient with each dollar of assets it utilizes for everyday operations.Ravenquest Biomed Ownership Allocation
Ravenquest Biomed owns a total of 123.62 Million outstanding shares. Ravenquest Biomed holds 10.51 pct. of its outstanding shares held by insiders and 3.22 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Ravenquest Biomed Profitability Analysis
The company reported the revenue of 1.26 M. Net Loss for the year was (30.47 M) with profit before overhead, payroll, taxes, and interest of 801.29 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ravenquest Biomed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ravenquest Biomed and how it compares across the competition.
About Ravenquest Biomed Valuation
The pink sheet valuation mechanism determines Ravenquest Biomed's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ravenquest Biomed. We calculate exposure to Ravenquest Biomed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ravenquest Biomed's related companies.RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. RAVENQUEST BIOMED operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.
8 Steps to conduct Ravenquest Biomed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ravenquest Biomed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ravenquest Biomed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ravenquest Biomed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ravenquest Biomed's revenue streams: Identify Ravenquest Biomed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ravenquest Biomed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ravenquest Biomed's growth potential: Evaluate Ravenquest Biomed's management, business model, and growth potential.
- Determine Ravenquest Biomed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ravenquest Biomed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ravenquest Biomed Growth Indicators
Investing in growth stocks can be very risky. If the company such as Ravenquest Biomed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 112.9 M | |
| Retained Earnings | -36.1 M |
Complementary Tools for Ravenquest Pink Sheet analysis
When running Ravenquest Biomed's price analysis, check to measure Ravenquest Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ravenquest Biomed is operating at the current time. Most of Ravenquest Biomed's value examination focuses on studying past and present price action to predict the probability of Ravenquest Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ravenquest Biomed's price. Additionally, you may evaluate how the addition of Ravenquest Biomed to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |